Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancer.
| Autor: | Zhao Y; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute., Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute.; Department of Immunology, Harvard Medical School.; Department of Neurology, Brigham & Women's Hospital, Boston, Massachusetts, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Current opinion in oncology [Curr Opin Oncol] 2024 May 01; Vol. 36 (3), pp. 136-142. Date of Electronic Publication: 2024 Feb 07. |
| DOI: | 10.1097/CCO.0000000000001023 |
| Abstrakt: | Purpose of Review: Neoadjuvant (presurgical) immune checkpoint blockade (ICB) has shown promising clinical activity in head and neck cancer and other cancers, including FDA approvals for neoadjuvant approaches for triple-negative breast cancer and nonsmall cell lung cancer. Here we will review recent data from clinical trials in head and neck squamous cell carcinoma (HNSCC), including mechanistic studies highlighting local and systemic effects on T cell-mediated immunity. Recent Findings: A series of clinical trials of neoadjuvant ICB have documented evidence of clinical activity, including clinical to pathologic downstaging and pathologic response in a subset of patients. Also, emerging data suggest improved survival outcomes for patients with tumors responsive to neoadjuvant ICB. In depth mechanistic studies have documented intra-tumoral expansion of CD8 T cell populations characterized by tissue residency and cytotoxicity programs. Treatment also leads to expansion of activated CD8 T cells in the blood, many of which share TCR sequences with tumor-infiltrating T cells. The frequency of activated circulating CD8 T cell populations is correlated with the degree of pathologic response within tumors. Summary: Even a short duration of neoadjuvant immunotherapy can enhance local and systemic tumor-reactive T cell populations. Downstaging induced by neoadjuvant ICB can reduce the extent of surgical resection in this anatomically sensitive location. (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|